ArticleJournal of medicinal chemistry2021

Nonpeptidic, Polo-Box Domain-Targeted Inhibitors of PLK1 Block Kinase Activity, Induce Its Degradation and Target-Resistant Cells.

Danda Chapagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.